QIAGEN Drives The Development Of Companion Diagnostics With Two Key Appointments
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MoreSearch Results for: prostate cancer
Urine Test for Kidney Cancer a Step Closer to Development
Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.
Read More
Spotlight On Vitamin D Testing
Testing is on the rise as deficiency is associated with cancer, stroke, osteoporosis, and other disorders.
Read MoreBioImagene Adds New Companion Algorithms for Colon Cancer
BioImagene Inc, the leading provider of end-to-end digital pathology solutions, today announced the availability of Companion Algorithms for colon cancer in their Virtuoso digital pathology software.
Read MoreClinical Utility of DiagnoCure’s PCA3 Prostate Cancer Marker Confirmed
DiagnoCure Inc announced that the clinical utility of the PROGENSA PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline’s REDUCE trial of dutasteride.
Read More